# UBRELVY

NDC: 0023-6498
Generic name: ubrogepant
Labeler / Manufacturer: Allergan, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20191223

FDA application: NDA211765

## Active ingredients

- UBROGEPANT: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0023-6498"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0023-6498
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd9f9458-fd96-4688-be3f-f77b3d1af6ab